Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | PNMT | P11086 | 1/20 | 0.37 |
| ▸ | IMPDH2 | P12268 | 3/20 | 0.37 |
| ▸ | IMPDH1 | P20839 | 2/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | AR | P10275 | 1/20 | 0.34 |
| ▸ | STAT3 | P40763 | 1/20 | 0.34 |
| ▸ | DRD1 | P21728 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | HTT | P42858 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 3/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14627618 | 0.80 | MAPT (0.35) | CA1CA2PNMTIMPDH2IMPDH1 | |
| SCHEMBL12742936 | 0.78 | CA1 (0.39) | CA1CA2IMPDH2IMPDH1TDP1 | |
| SCHEMBL14596146 | 0.76 | CYP3A4 (0.39) | PNMTTDP1CYP3A4DRD1MEN1 | |
| SCHEMBL8468481 | 0.75 | CYP3A4 (0.46) | CA1CA2IMPDH2TDP1CYP3A4 | |
| SCHEMBL30669868 | 0.75 | CYP3A4 (0.46) | CA1CA2IMPDH2TDP1CYP3A4 | |
| SCHEMBL3425344 | 0.75 | CYP3A4 (0.38) | TDP1CYP3A4DRD1 | |
| SCHEMBL3940105 | 0.75 | ALDH1A1 (0.46) | TDP1CYP3A4DRD1ALDH1A1TSHR | |
| SCHEMBL30399979 | 0.73 | TSHR (0.47) | CA1CA2TDP1CYP3A4AR | |
| SCHEMBL28626744 | 0.73 | TSHR (0.47) | CA1CA2TDP1CYP3A4AR | |
| SCHEMBL15659620 | 0.73 | SMN1; SMN2 (0.41) | CA1CA2TDP1CYP3A4DRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070010695-A1 | Diphosphines, preparation and uses thereof | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2007-01-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070010695-A1 | Diphosphines, preparation and uses thereof | MPI, ITPA, DCPS | CA1 3712/4885CA2 2115/4885PNMT 728/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.